By addressing current knowledge gaps and leveraging novel analogs and technologies, VD/VDR modulation could evolve into a cornerstone of personalized sepsis care, offering dual benefits as an immune enhancer and anti-inflammatory agent across all disease stages. The gene discussed is VDR; the disease is Sepsis.